Dr. Reddy's Laboratories

Overview

Dr. Reddy's Laboratories is a prominent Indian pharmaceutical company founded in 1984 and headquartered in Hyderabad. With a workforce of approximately 25,498 employees, it operates in over 66 countries and reported group revenues of around USD 2.83 billion. The company has a strong commitment to affordable medicines and innovation, supported by a dedicated research foundation established in 1993.

The company operates through three main business segments: Global Generics, which focuses on manufacturing and marketing generic pharmaceutical products; Pharmaceutical Services and Active Ingredients, which produces active pharmaceutical ingredients and offers contract research and manufacturing services; and Proprietary Products, which develops novel pharmaceutical products, including biosimilars. Dr. Reddy's offers a diverse range of products, including branded and generic formulations, and has expanded into nutrition products with brands like Celevida. The company also engages in patient-centric initiatives and has a foundation dedicated to health, education, and sustainability.

Basic Information

Contact Details

• Phone: +91 40490 02900
• Website: drreddys.com
• LinkedIn: linkedin.com/company/dr--reddys-laboratories

Key Focus Areas & Initiatives

• pharmaceutical
• specialty
• biogeneric
• api
• generic formulations
• biotechnology: pharmaceutical preparations
• health care
• pharmaceutical manufacturing
• health innovation
• clinical research
• emerging markets
• medicinal chemistry
• api manufacturing
• biopharmaceuticals
• regulated markets
• therapeutic areas
• biosimilar drugs
• active pharmaceutical ingredients
• manufacturing facilities
• apis
• quality assurance
• regulatory compliance
• biosimilar development
• drug discovery
• medical products
• healthcare innovation
• critical care products
• pipeline development
• biosimilar manufacturing
• biosimilar pipeline development
• biotechnology
• fda-approved
• biosimilar biologics
• drug innovation
• manufacturing
• biosimilar market entry
• biotech
• new chemical entities
• generic drugs
• medicinal products
• healthcare
• medical devices
• generics
• environmental standards
• pharmaceuticals
• medicines
• healthcare solutions
• biosimilar monoclonal antibody
• diagnostic kits
• nutrition products
• biosimilar reditux
• market regulation
• drug pipeline
• biosimilar market
• innovative drugs
• regulatory standards
• biosimilar therapeutics
• biosimilar pipeline
• market expansion
• product portfolio
• product launches
• diagnostics
• environmental sustainability
• biosimilar monoclonal antibody for lymphoma
• global healthcare
• healthcare access
• healthcare services
• global markets
• affordable medicines
• quality management
• biosimilars
• biosimilar clinical trials
• fda approval
• healthcare providers
• b2b
• government
• services
• pharmaceutical and medicine manufacturing
• oncology
• cardiology
• dermatology
• patient care
• supply chain
• medical
• health, wellness & fitness
• mechanical or industrial engineering
• hospital & health care

Technologies Used

• CloudFlare Hosting
• Cloudflare DNS
• Create React App
• Microsoft Office 365
• Outlook
• Remote
• Umbraco

Affiliated Organizations & Regional Branches

• Dr. Reddy's Brasil
• Habitrol
• MenoLife
• Dr. Reddy's Chile
• redi-Group Quality Services (Beijing) Co., Ltd 瑞迪瑞普质量技术(北京)有限公司
• Reddy Pharma Iberia, S.A.
• Reddy Farmako
• DR. REDDY'S LABORATORIES (EU) LIMITED
• MenoLabs: Science-backed menopause support
• nimbus health GmbH